The latest update is out from LABORATORIO REIG JOFRE ( (ES:RJF) ).
REIG JOFRE reported a 12% increase in net results for the first quarter of 2025, driven by operational improvements and international growth, with revenues reaching 88 million euros. The company’s strategic focus on international markets, particularly in Europe and Asia, has led to a significant increase in sales outside Spain, now accounting for 60% of total revenues, while domestic sales decreased by 10%.
More about LABORATORIO REIG JOFRE
REIG JOFRE is a pharmaceutical company listed on the Spanish stock exchange, operating in over 70 countries. It specializes in pharmaceutical technologies, specialty pharmacare, and consumer healthcare, with a strong focus on international expansion and reducing dependence on the domestic market.
Average Trading Volume: 34,395
Technical Sentiment Signal: Buy
Current Market Cap: €240.2M
See more insights into RJF stock on TipRanks’ Stock Analysis page.